Exhibit 10.15
AMENDMENT No. 2
to
THE DEVELOPMENT AND MANUFACTURING
SERVICES AGREEMENT
Dated 12 AUGUST 2003
Between
LONZA BIOLOGICS ***
and
TRUBION PHARMACEUTICALS, INC. (formerly known as GENECRAFT INC.)
Schedule 1 - Definitions and Specifications
Definition of term "Product"
Schedule 2 - Services
New Stages
Schedule 3 - Price and Payment
Price and Payment for New Stages
THIS SECOND AMENDMENT ("Second Amendment") is made the 2nd day of December,
2003
BETWEEN
LONZA BIOLOGICS *** (hereinafter referred to as "LB"), and
TRUBION PHARMACEUTICALS, INC. (formerly known as GENECRAFT, INC.) of ▇▇▇▇
▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇, ▇▇▇ (herein after referred to as the
"Customer")
WHEREAS
A. LB and the Customer entered into a development and manufacturing
services agreement dated 12 August 2003 pursuant to which LB agreed to provide
Services to the Customer (as amended by the Amendment No. 1 between the parties
dated November 7, 2003, "the Agreement"), and,
B. The Customer now wishes LB to perform additional Services under the
Agreement, and,
C. LB is willing to perform such additional Services on the terms to be
agreed upon by the parties and incorporated into the Agreement, and
D. The parties wish to amend the Agreement in accordance with Clause 12.5
thereto.
NOW THEREFORE IT IS HEREBY AGREED as follows:
1 SCHEDULE 1 SHALL BE AMENDED AS FOLLOWS:
The definition of the term "Product" shall be amended to read in its
entirety as follows:
"Product" shall mean the Small Modular ImmunoPharmaceutical (SMIP) produced
by the ***, which targets and binds to human CD20."
2 SCHEDULE 2 SHALL BE AMENDED TO ADD THE FOLLOWING STAGES:
Stage 4 -***;
Stage 5 -***; and
Stage 6 -***.
ALL ADDITIONAL SERVICES DESCRIBED IN THIS SECOND AMENDMENT WILL BE
PERFORMED ON TIMESCALES TO BE AGREED UPON BY THE PARTIES.
3 SCHEDULE 3 TO THE AGREEMENT SHALL BE AMENDED TO INCLUDE PROVISION FOR
PAYMENT FOR THE ABOVE MENTIONED ADDITIONAL SERVICES, ON TERMS TO BE AGREED
BETWEEN THE PARTIES.
4 LB HEREBY REPRESENTS AND WARRANTS THAT, AS OF THE EFFECTIVE DATE OF THIS
SECOND AMENDMENT, IT IS NOT A PARTY TO ANY AGREEMENT THAT WOULD PREVENT IT FROM
PERFORMING THE ADDITIONAL SERVICES DESCRIBED IN THIS SECOND AMENDMENT OR
OTHERWISE FULFILLING ITS OBLIGATIONS UNDER THIS SECOND AMENDMENT, AND LB HEREBY
COVENANTS THAT IT SHALL NOT ENTER INTO ANY SUCH CONFLICTING AGREEMENT DURING THE
TERM OF THE AGREEMENT, AS AMENDED BY THIS SECOND AMENDMENT.
5 THE PARTIES SHALL ENTER GOOD FAITH NEGOTIATIONS TO AMEND THE AGREEMENT TO
INCLUDE THE TERMS AND CONDITIONS THAT WILL GOVERN AND APPLY TO THE ADDITIONAL
SERVICES TO BE PERFORMED BY LONZA UNDER THIS SECOND AMENDMENT. SHOULD SUCH GOOD
FAITH NEGOTIATIONS FAIL, NEITHER PARTY SHALL HAVE ANY OBLIGATION WITH RESPECT TO
SUCH ADDITIONAL SERVICES.
6 THE PARTIES AGREE THAT THIS AMENDMENT SHALL BECOME EFFECTIVE UPON THE
EXCHANGE OF SIGNATURE COPIES BY FACSIMILE TRANSMISSION.
7 SAVE AS HEREIN PROVIDED ALL OTHER TERMS AND CONDITIONS OF THE AGREEMENT
SHALL REMAIN IN FULL FORCE AND EFFECT.
AS WITNESS the hands of the duly authorised representatives of the parties
hereto the day and year first above written.
Signed for and on behalf of ***
LONZA BIOLOGICS *** ----------------------------------------
***
----------------------------------------
TITLE
Signed for and on behalf of ▇▇▇▇▇ ▇▇▇▇▇▇▇▇
TRUBION PHARMACEUTICALS, INC President & CEO
TITLE
-2-